Men's Weekly

.

Zuellig Pharma and Substipharm Biologics partner to expand access to IMOJEV® vaccine for Japanese encephalitis across Asia

New commercialisation agreement builds on existing partnership with Zuellig Pharma

SINGAPORE - Media OutReach Newswire - 16 January 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced its commercialisation partnership with pharmaceutical company Substipharm Biologics, to expand access of the IMOJEV® Japanese encephalitis vaccine across nine markets in Asia, including Brunei, Cambodia, Hong Kong, Malaysia, Myanmar, Philippines, Singapore, Taiwan and Vietnam.

More Articles ...

  1. Omdia ranks Infobip a Leader in the CPaaS Universe report for second year
  2. A cyber event is the top business risk for 2024 globally and in Asia
  3. MĀUA Nusa Penida, Bali, Indonesia Wins Five Top Awards, Reinforcing its Status as a Premier Island Resort
  4. Uncover Fortune Finds in Singapore Early This Lunar New Year with iShopChangi's Deals
  5. Results of the IX Digital Asset Industry Classification System ("DAICS®") 2023 2H Review
  6. Lenovo Unleashes AI-Powered Creativity and Productivity Devices and Solutions at CES 2024
  7. Dynamic duo of pacts serve as ballast in China-ASEAN cooperation
  8. WellCell Successfully Listed on the Main Board of The Stock Exchange of Hong Kong Limited
  9. Indonesian President visits VinFast manufacturing complex
  10. THINK CHINA Awarded Asia’s ‘eCommerce Team of the Year’ for Partnership with Europe’s Premier Luxury Brands

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34